The only one that may have been excercising an option was Roger Gale's $ 25,000 or so purchase of just over 300,000 shares on 4-1-2008. All the remaining 10 million are still unexcercised options. No one need excercise these riskless options until the price is pumped up. When it is they can sell you the shares at $ .13 and double their money.
GIO. You have a few things going for you by buying at today's market price.
1. At $ .053 - $ .065 you will be buying below most but not all of the options available.
2. The company needs to keep the stock price above $ .052 to keep getting the Fusion Capital money.
3. I truly believe that there will be a China SFDA approval in near future and you will see a "pop" on the price. (Now all of us have been saying this for over 2 years, but this time we really, really really mean it.)
4. According to 10K the UAE rapid test is now approved (page 11 and 19 of 10K) again which means that the distributor has been replaced according to message sent by Roger in December.
And related to that, I think, there was a question about the UAE. "Yes, we have opened our office in the UAE. We are building up our operations there. We have a very talented, very committed small team based in Dubai. They have something of a disadvantage in that we did make sales in the UAE last year and the approval in UAE has now come to an end and they’re reapplying for re-approval.
The approval in UAE, as in many countries, is directly tied to a particular distributor. Now that we have terminated that distributor, we’re seeking a new distributor. Once that new distributor is appointed, then we will reapply for the approval process and sales will begin again in the UAE. That is not uncommon in many of these countries."
5. According to 10K it appears that Calypte got 1.206 million from a joint venture in 2007, up from less than $ 600,000 in 2006. The only one I am aware of is the maxim Biomedical one where Calypte gets 20% of the profits.
So its possible that this latest round of financial set-ups COULD and let me stress COULD mean in a "best case scenario" for Calypte investors that:
1. SFDA approval is "coming through", hopefully with a big order attached
2. News of new UAE distributor and hopefully a large stocking order.
3 Details of the 1.206 million income from someone will be revealed. The fact that it doubled over last year is impressive. The fact that it was over TWICE Calypte's actual sales is stunning.
4. Orders from India, UAE, Russia, South Africa in first quarter, could be awesome.
Quoting Roger Gale in December:
"However, the process of making sales in the Middle East, in Russia, in India and China, less so in China, but in those other three countries, in particular, we believe we are on track. We have not deviated from our efforts to sell. And looking forward to early next year, what we haven’t sold this year we believe we will be selling next year."
Gotta take the man at his word. He is "due".
Wonder how close to his 15 million annual projection he was be at end first quarter.
So you guys may be getting the mother of all pumps (at least since September - October of 2003) very shortly with tremendous good news based on items and statements above.
Or it may just be the same old "safe harbor" failed projections scenario,
This is one man's opinion only and is given with a bit of tongue in cheek. Please do you own DD before buying or selling any stock.
